­
­
­
­

Inventi Impact: Urology & Nephrology

Articles

  • Inventi:hkd/18459/15
    The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer
    01-Jan-1970 Research 2016 : January - March
    Andres F Correa, Katherine Theisen, Matthew Ferroni, Jodi K Maranchie, Ronald Hrebinko, Benjamin J Davies, Jeffrey R Gingrich

    Background. Thirty to forty percent of patients with high grade nonmuscle invasive bladder cancer (NMIBC) fail to respond to\nintravesical therapy with bacillus Calmette-Guerin (BCG). Interferon-

    How to Cite this Article
    CC Compliant Citation: Andres F. Correa, Katherine Theisen,\nMatthew Ferroni, et al., â??The Role of Interferon in the Management\nof BCG Refractory Nonmuscle Invasive Bladder Cancer,â? Advances\nin Urology, vol. 2015, Article ID 656918, 6 pages, 2015.\ndoi:10.1155/2015/656918, http://creativecommons.org/\nlicenses/3.0/.
    Download Full Text